FierceBiotech

Twist Bioscience launches research panel for screening COVID-19, other respiratory viruses

Synthetic DNA manufacturer Twist Bioscience launched a new research panel focused on identifying respiratory diseases, including the novel coronavirus behind the COVID-19 pandemic. Using a ...
Healio

FDA clears Qiagen’s respiratory syndromic testing panel

Please provide your email address to receive an email when new articles are posted on . Qiagen’s respiratory panel can detect 21 viral and bacterial pathogens that can cause upper respiratory ...
Business Wire

Twist Bioscience Adds Respiratory Virus Panel to Infectious Disease Product Line

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
Nasdaq

QIAGEN (QGEN) Wins FDA Nod for QIAstat-Dx Respiratory Panel Plus

QIAGEN N.V. QGEN recently secured FDA clearance for the QIAstat-Dx Respiratory Panel Plus syndromic test. Previously authorized under the FDA Emergency Use Authorization (“EUA”) as the QIAstat-Dx ...
Healio

Multiplex PCR assay detects four respiratory viruses with single swab

Please provide your email address to receive an email when new articles are posted on . The BD MAX Respiratory Viral Panel detected and differentiated between influenza A and B respiratory syncytial ...